| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
3 companies
Smither John W is a Director at GENELUX Corp with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 14 sells.
Estimated insider holdings value: $613K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2024 | GNLX Genelux Corp | Director | Buy | 6,250 | $0.00 | - | +90.3% | -25.4% | -12.1% | |
| Sep 13, 2023 | GNLX Genelux Corp | Director | Sell | 900 | $20.78 | $18,702.00 | -11.5% | -40.2% | -87.4% | |
| Mar 10, 2021 | ARQT Arcutis Biotherapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,750 | $32.90 | $57,575.00 | -1.3% | -13.2% | -45.4% | |
| Mar 1, 2021 | ARQT Arcutis Biotherapeutics, Inc. | Chief Financial Officer | Sell | 773 | $34.20 | $26,439.69 | -3.1% | -21.6% | -50.0% | |
| Feb 10, 2021 | ARQT Arcutis Biotherapeutics, Inc. | Chief Financial Officer | Sale+OE | 2,750 | $35.64 | $98,010.00 | -2.4% | -18.0% | -56.0% | |
| Feb 1, 2021 | ARQT Arcutis Biotherapeutics, Inc. | Chief Financial Officer | Sale+OE | 5,000 | $35.00 | $175,000.00 | -4.2% | - | - | |
| Jan 19, 2021 | ARQT Arcutis Biotherapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,750 | $30.00 | $52,500.00 | -1.5% | - | - | |
| Dec 14, 2020 | ARQT Arcutis Biotherapeutics, Inc. | Chief Financial Officer | Sale+OE | 5,250 | $30.00 | $157,500.00 | -4.2% | - | - | |
| Sep 29, 2020 | ARQT Arcutis Biotherapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,750 | $30.00 | $52,500.00 | -1.4% | - | - |